Attends OTS 2026 Annual Meeting in Denver

DLeader Founder & CEO Qingwen Chen attended the 22nd Annual Meeting of the Oligonucleotide Therapeutics Society (OTS), held October 11–14, 2026, in Denver, Colorado, USA. A leading international conference in oligonucleotide therapeutics, the meeting brought together researchers and industry representatives to share scientific advances and discuss challenges in therapeutic development.

During the meeting, Chen explored the latest research and connected with researchers and companies from around the world. These insights and relationships will inform the continued development of KumiChem™, DLeader’s AI platform for RNA drug discovery, and future research collaborations.